Reaktion #1795112

ord-3b7f1bfa32c94f0893791965d8a29a1b

Reaktionsgleichung

Cl
HCl
NS(=O)(=O)c1ccn2c1C(=O)OCC2
3,4-dihydro-1-oxo-1H-pyrrolo[2,1-c][1,4]oxazine-8-sulfonamide
COc1nc(C)nc(NC(=O)Oc2ccccc2)n1
phenyl (4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamate
C1CCC2=NCCCN2CC1
1,8-diazabicyclo[5.4.0]undec-7-ene
COc1nc(C)nc(NC(=O)NS(=O)(=O)c2ccn3c2C(=O)OCC3)n1
title compound
Ausbeute 56.5%
COc1nc(C)nc(NC(=O)NS(=O)(=O)c2ccn3c2C(=O)OCC3)n1
3,4-Dihydro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]-1-oxo-1H-pyrrolo[2,1-c][1,4]-oxazine-8-sulfonamide
Ausbeute 56.5%

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.STIRRINGwith stirring
  2. 2
    SonstigeThe product crystallized from the two phase mixture
  3. 3
    Filtrationwas collected by filtration

Vorschrift

A solution of 40 mg (0.185 mmol) of 3,4-dihydro-1-oxo-1H-pyrrolo[2,1-c][1,4]oxazine-8-sulfonamide and 53 mg (0.204 mmol) of phenyl (4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamate in 0.8 mL acetonitrile was treated with 0.03 mL 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and then stirred 40 minutes at ambient temperature. Water (5 mL) plus 0.5 mL 1N HCl was added with stirring followed by ca. 1 mL of ethyl ether. The product crystallized from the two phase mixture and was collected by filtration to afford 40 mg of the title compound, m.p. 204°-207° C. dec.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05356862uspto-grants-1994_10